Sunitinib in a worldwide treatment-use trial of patients with imatinib, resistant/intolerant gastrointestinal stromal tumor: detailed analysis of survival and safety.

Category Primary study
JournalAnn Oncol
Year 2008
This article has no abstract
Epistemonikos ID: 184701a90a161879c52b922aee357e00eee31401
First added on: Oct 13, 2017